Comparison of questionnaire responses with biomarkers of tobacco smoke exposure in a Canadian birth cohort at three months of age by McLean, Kathleen et al.
MEETING ABSTRACT Open Access
Comparison of questionnaire responses with
biomarkers of tobacco smoke exposure in a
Canadian birth cohort at three months of age
Kathleen McLean1*, Bruce Lanphear1, Amanda J Wheeler2, Jeff Brook3, James Scott4, Ryan Allen1, Michael Brauer5,
Malcolm Sears6, Padmaja Subbarao7, Stuart Turvey8, Allan Becker9, Piush Mandhane10, Tim Takaro1
From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2013
Toronto, Canada. 3-6 October 2013
Background
Exposure to tobacco smoke increases the risk for several
adverse health effects in children including wheeze,
asthma, and asthma exacerbation [1,2]. Accurately
assessing tobacco smoke exposure is important for
understanding and preventing these health effects.
Questionnaires are a flexible and relatively inexpensive
method of assessing exposure, but biomarkers of tobacco
smoke exposure are considered more accurate. We
developed questionnaire-based exposure models predict-
ing urinary levels of biomarkers cotinine and trans-
3’-hydroxycotinine (3HC) (metabolites of nicotine) in
3-month old infants using parent-reported questionnaire
responses about tobacco smoke exposure from the
Canadian Healthy Infant Longitudinal Development
(CHILD) Study.
Methods
We used a manual model building process to build multi-
ple linear regression models predicting urinary concentra-
tions of cotinine, 3HC, and the sum of cotinine and 3HC
on a molar basis (Cot+3HC) for 987, 1003, and 983
infants, respectively. Questions were included on the
infant’s exposure assessed at 3 months of age and tobacco
smoke odour in the home. We also included questions on
maternal smoking status and history, passive exposure,
and family socio-economic status assessed during
pregnancy, as potential indirect measures of the infant’s
exposure at 3 months. Adjusted R2 values were maximized
in the final models.
Results
During pregnancy, the prevalence of maternal smoking
was 2.4 %, and 115 (11.4 %) mothers reported smoking
by at least 1 person at home. Of the 144 (14.3 %) infants
whose mothers reported that smoking occurred at home
when their child was 3 months, 129 (89.6%) and
136 (94.4%) had cotinine and 3HC levels above the
detection limit (0.03 ng/mL), respectively. Of the
811 infants who had no parent-reported exposure at
3 months, 538 (66.3%) and 715 (88.2%) had detectable
cotinine and 3HC levels, respectively. After correcting
for urine dilution, the geometric mean levels were
0.085 ng/mL for cotinine, 0.20 ng/mL for 3HC, and
1.62 picomole/mL for Cot+3HC. The final questionnaire
models explained 43.4%, 41.0%, and 42.9% of the
variance in cotinine, 3HC, and Cot+3HC levels,
respectively.
Conclusions
Our results indicate that exposure of these infants to
tobacco smoke is not completely captured by question-
naires, suggesting that exposure assessment could be
improved by using a combination of biomarker and ques-
tionnaire methods. Though more detectable, the inclusion
of 3HC did not increase the ability of the questionnaires
to explain variance in metabolite levels, but 3HC may be
important since the ratio of 3HC to cotinine can be used
to quantify the rate of nicotine metabolism and variation
within populations [3,4].
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